1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Proteomics: Technologies and Global Markets

Proteomics: Technologies and Global Markets

  • February 2015
  • -
  • BCC Research
  • -
  • 223 pages

REPORT HIGHLIGHTS

The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.

This report provides:

An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.

SCOPE AND FORMAT

The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays and LOAC. It also covers the research, drug discovery and development, diagnostics and applied end-user market segments. The main geographical markets—North America, Europe, Asia and Rest of World (ROW)—are included.
The MS market is covered by instrument type, MS consumables, product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth through 2019.
Technology status and market driving forces are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.
Key industry acquisitions and strategic alliances are given for the three-year period from 2012 through 2014.
This report also examines the main patent trends within the industry and profiles 108 proteomics companies.

Table Of Contents

Proteomics: Technologies and Global Markets

Chapter- 1: Introduction - Complimentary 4

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC RESEARCH REPORTS
ANALYST'S CREDENTIALS
BCC RESEARCH ONLINE SERVICES
DISCLAIMER

Chapter- 2: SUMMARY 3

Table Summary : GLOBAL PROTEOMIC MARKET BY END-USER INDUSTRY, THROUGH 2019
Figure Summary : GLOBAL PROTEOMIC MARKET BY END-USER INDUSTRY, 2013-2019

Chapter- 3: OVERVIEW 6

PROTEOMIC TECHNOLOGIES
SCOPE OF REPORT
PROTEOMICS MARKET
DRIVING FORCES FOR PROTEOMICS INDUSTRY GROWTH
THE PROTEOMICS INDUSTRY

Chapter- 4: PROTEOMICS TECHNOLOGIES 12

INTRODUCTION TO TECHNOLOGY PLATFORMS
MS-BASED PROTEOMICS TECHNOLOGIES
BIOCHIP-BASED PROTEOMICS TECHNOLOGIES
MULTIPLEX PROTEOMICS SYSTEMS
PROTEOGENOMICS
RECENT ADVANCES IN PROTEOMIC TECHNOLOGIES

Chapter- 5: PROTEOMIC APPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT 4

TARGET DISCOVERY
LEAD IDENTIFICATION
LEAD OPTIMIZATION
PRECLINICAL STUDIES
Table 11 : PROTEOMIC APPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT

Chapter- 6: PROTEOMICS SCIENTIFIC INITIATIVES 4

Table 12 : LARGE-SCALE PROTEOMIC INITIATIVES

Chapter- 7: CLINICAL PROTEOMICS APPLICATIONS 44

CANCER APPLICATIONS
INFECTIOUS DISEASES
DIABETES
NEUROLOGICAL DISORDERS
IMMUNE DISEASES
CARDIOVASCULAR DISEASE
PREECLAMPSIA
Table 13 : STRATEGIES FOR OVERCOMING HIGH-ABUNDANCE PROTEINS IN CLINICAL SAMPLES

Chapter- 8: PROTEOMICS INDUSTRY 38

INDUSTRY ACQUISITIONS
INDUSTRY STRATEGIC ALLIANCES
MASS SPECTROMETRY INDUSTRY
CHROMATOGRAPHY INDUSTRY
PROTEOMICS-BASED DRUG DISCOVERY AND DEVELOPMENT INDUSTRY
PROTEOMICS BIOCHIP INDUSTRIES
CHEMICAL PROTEOMICS INDUSTRY
ANTIBODY REAGENT INDUSTRY
MULTIPLEX PROTEIN DIAGNOSTICS INDUSTRY
DRIED BLOOD SPOTTING PROTEOMICS INDUSTRY
SINGLE CELL PROTEOMICS INDUSTRY

Chapter- 9: PROTEOMICS MARKETS 36

DRIVING FORCES OF PROTEOMICS INDUSTRY GROWTH
GLOBAL PROTEOMICS MARKETS

Chapter- 10: PROTEOMICS PATENTS 3

BIOCHIP PATENTS
MASS SPECTROMETRY PATENTS

Chapter- 11: COMPANY PROFILES 69

ABCODIA LTD.
ABLYNX NV
ACTIVIOMICS LTD.
ACTIVX BIOSCIENCES INC.
ADVANCED PROTEOME THERAPEUTICS INC.
AGILENT TECHNOLOGIES INC.
APPLIED MICROARRAYS
APPLIED PROTEOMICS
ARRAYIT CORP.
ASTUTE MEDICAL INC.
AVACTA GROUP PLC
AYOXXA BIOSYSTEMS GMBH
BIOCARTIS NV
BIODESIX INC.
BIOGNOSYS AG
BIOMERIEUX SA
BIOPROXIMITY LLC
BIO-RAD LABORATORIES INC.
BIO-TECHNE INC.
BRUKER CORP.
CAMBRIDGE PROTEIN ARRAYS LTD.
CAPRION PROTEOME INC.
CAPROTEC BIOANALYTICS GMBH
CARMENTA BIOSCIENCE INC.
CDI LABORATORIES INC.
CRELUX GMBH
CRESCENDO BIOSCIENCE
CRYSTALGENOMICS INC.
CYVEK INC.
DANAHER CORP.
DIASSESS
DIGILAB INC.
EPICYPHER INC.
EVOTEC AG
FLUIDIGM CORP
GENERAL ELECTRIC CO.
GLAXOSMITHKLINE PLC
GLOBAL DISCOVERY BIOSCIENCES
GL SCIENCES INC.
HEALTHTELL INC.
HYBRIGENICS SA
IMMUNOVIA AB
IMTAKT CORP.
INTEGRATED DIAGNOSTICS
INDI MOLECULAR
IRIS INTERNATIONAL INC.
LABCYTE INC.
LEAP TECHNOLOGIES INC.
LUMINEX CORP.
MERCK and CO. INC.
MERCK KGAA
MICROLYTIC
MRM PROTEOMICS INC.
MOSAIQUES DIAGNOSTICS AND THERAPEUTICS AG
MYCARTIS
MYRIAD GENETICS INC.
NEWOMICS INC.
NIRMIDAS BIOTECH INC.
OLINK BIOSCIENCE
ONCOPLEX DIAGNOSTICS
OPKO HEALTH INC.
PERKINELMER INC.
PERSONALIZED CANCER THERAPY INC.
PFIZER INC.
PHENOMENEX INC.
PHYLOGICA LTD.
PRESSURE BIOSCIENCES INC.
PROMETIC LIFE SCIENCES INC.
PROTAGEN AG
PROTEA BIOSCIENCES INC.
PROTEOCYTE DIAGNOSTICS INC.
PROTEOGENIX
PROTEOME SCIENCES PLC
PROTEOMICS INTERNATIONAL PTY LTD
PROTEOVISTA LLC
PROVISTA DIAGNOSTICS INC.
QIAGEN NV
QUANSYS BIOSCIENCES
QUANTERIX INC.
QUEST DIAGNOSTICS INC.
REPLIGEN CORP.
RETROGENIX LTD.
SAMDI TECH INC.
SERA PROGNOSTICS
SHIMADZU CORP.
SHISEIDO COMPANY LTD.
SHOWA DENKO KK
SIGMA ALDRICH
SINGULEX INC.
SISCAPA ASSAY TECHNOLOGIES INC.
SOMALOGIC INC.
SPHERE FLUIDICS LTD.
SPOTON CLINICAL DIAGNOSTICS LIMITED
SQI DIAGNOSTICS
SYNAGEVA BIOPHARMA
T2 BIOSYSTEMS
TALKING20 INC.
THERANOSTICS HEALTH
THERMO FISHER SCIENTIFIC INC.
THORNE DIAGNOSTICS INC.
TOSOH CORP.
UNIVERSAL BIOSENSORS LTD.
VERMILLION INC.
VG LIFE SCIENCES INC.
WATERS CORP.
XENCOR INC.
YMC CO. LTD.
ZEPHYRUS BIOSCIENCES INC.

List of Tables

Summary Table : GLOBAL PROTEOMIC MARKET BY END-USER INDUSTRY, THROUGH 2019
Table 1 : ARRAY VERSUS LOAC BIOCHIPS
Table 2 : SCOPE OF REPORT
Table 3 : GLOBAL PROTEOMIC MARKET BY PLATFORM, THROUGH 2019
Table 4 : PROTEOMIC INDUSTRY GROWTH DRIVING FORCES
Table 5 : BIOCHIP INDUSTRY COMPARISONS
Table 6 : MASS SPECTROMETER PLATFORMS
Table 7 : BIOCHIP-BASED PROTEOMIC TECHNOLOGIES
Table 8 : PLANAR-BASED VERSUS BEAD-BASED ARRAYS
Table 9 : ADVANTAGES OF MULTIPLEXING FOR DIAGNOSTICS
Table 10 : TECHNICAL ADVANCES IN PROTEOMICS
Table 11 : PROTEOMIC APPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT
Table 12 : LARGE-SCALE PROTEOMIC INITIATIVES
Table 13 : STRATEGIES FOR OVERCOMING HIGH-ABUNDANCE PROTEINS IN CLINICAL SAMPLES
Table 14 : ESTIMATED U.S. INCIDENCE AND DEATHS FOR SELECTED CANCERS, 2010 AND 2013
Table 15 : STATUS OF BLADDER CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 16 : ESTIMATED NUMBER OF ANNUAL BREAST CANCER TREATMENT DECISIONS IN THE U.S. BY CANCER CLASSIFICATION
Table 17 : BREAST CANCER MDX TECHNOLOGY PLATFORMS
Table 18 : STATUS OF NEXT GENERATION BREAST CANCER TESTS
Table 19 : STATUS OF GASTRIC/STOMACH CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 20 : STATUS OF KIDNEY CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 21 : FIVE-YEAR SURVIVAL RATES FOR NON-SMALL CELL LUNG CANCER
Table 22 : STATUS OF LUNG CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 23 : STATUS OF LYMPHOMA CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 24 : EARLY SCREENING OVARIAN CANCER TESTS
Table 25 : STATUS OF OVARIAN CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 26 : STATUS OF PAN-CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 27 : STATUS OF PROSTATE CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 28 : STATUS OF THYROID CANCER NEXT GENERATION DIAGNOSTICS TESTS
Table 29 : ALZHEIMER'S DISEASE DIAGNOSTIC APPROACHES
Table 30 : MULTIPLEX AUTOIMMUNE TESTING MARKET
Table 31 : PREECLAMPSIA DIAGNOSTICS TESTS
Table 32 : PROTEOMIC INDUSTRY ACQUISITIONS, 2012-2014
Table 33 : STRATEGIC ALLIANCES IN THE PROTEOMIC INDUSTRY, 2012-2014
Table 34 : MASS SPECTROMETRY INDUSTRY: PORTER FIVE FORCES ANALYSIS
Table 35 : FIRST-TIER MASS SPECTROMETRY COMPANIES
Table 36 : SECOND-TIER MASS SPECTROMETRY COMPANIES
Table 37 : GLOBAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY COLUMN MANUFACTURING COMPANIES
Table 38 : JAPANESE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY COLUMN LEADING MANUFACTURING COMPANIES
Table 39 : PROTEOMIC-BASED DRUG DISCOVERY INDUSTRY
Table 40 : KEY PEPTIDE MICROARRAY COMPANIES
Table 41 : HIGH DENSITY PROTEIN ARRAY COMPANIES
Table 42 : KEY ANTIBODY MICROARRAY COMPANIES
Table 43 : CHINA'S BIOCHIP INDUSTRY
Table 44 : LOAC COMPETITOR LANDSCAPE
Table 45 : ANTIBODY REAGENT MARKET, 2014
Table 46 : MULTIPLEX PROTEIN IN-VITRO DIAGNOSTICS COMPANIES
Table 47 : DRIED BLOOD SPOT PROTEOMICS INDUSTRY
Table 48 : SINGLE CELL PROTEOMICS INDUSTRY
Table 49 : PROTEOMIC INDUSTRY GROWTH DRIVING FORCES
Table 50 : GLOBAL PROTEOMIC MARKET BY END-USE INDUSTRY, THROUGH 2019
Table 51 : GLOBAL PROTEOMIC RESEARCH MARKET BY PLATFORM, THROUGH 2019
Table 52 : GLOBAL PROTEOMIC RESEARCH MARKET BY BIOCHIP PLATFORM, THROUGH 2019
Table 53 : GLOBAL PROTEOMIC DRUG DISCOVERY AND DEVELOPMENT PRODUCT MARKET BY PLATFORM, THROUGH 2019
Table 54 : GLOBAL PROTEOMIC BIOCHIP DRUG DISCOVERY AND DEVELOPMENT MARKET BY TYPE, THROUGH 2019
Table 55 : GLOBAL PROTEOMIC DIAGNOSTIC PRODUCT MARKET BY PLATFORM, THROUGH 2019
Table 56 : GLOBAL BIOCHIP DIAGNOSTIC MARKET BY TYPE, THROUGH 2019
Table 57 : GLOBAL PROTEOMIC DIAGNOSTIC PRODUCT MARKET BY DISEASE TYPE, THROUGH 2019
Table 58 : STATUS OF PROTEOMIC-BASED DIAGNOSTICS FOR DIABETES, NEUROLOGICAL, AUTOIMMUNE, INFECTIOUS DISEASE, HLA TYPING, AND CARDIOVASCULAR DISEASE APPLICATIONS
Table 59 : SEPSIS DIAGNOSTICS INDUSTRY
Table 60 : GLOBAL PROTEOMIC CANCER DIAGNOSTIC PRODUCT MARKET BY INDICATION, THROUGH 2019
Table 61 : GLOBAL MASS SPECTROMETRY MARKET BY PRODUCT TYPE, THROUGH 2019
Table 62 : GLOBAL MASS SPECTROMETRY MARKET BY END-USER INDUSTRY, THROUGH 2019
Table 63 : MRM-MS VERSUS MALDI MS IN CLINICAL APPLICATIONS
Table 64 : MS CLINICAL INDUSTRY
Table 65 : PHOSPHOPROTEOMICS PLATFORMS FOR CANCER APPLICATIONS
Table 66 : GLOBAL MASS SPECTROMETRY INSTRUMENT PROTEOMICS MARKET BY TECHNIQUE, THROUGH 2019
Table 67 : GLOBAL MASS SPECTROMETRY CONSUMABLE MARKET BY TYPE, THROUGH 2019
Table 68 : GLOBAL PROTEOMIC BIOCHIP MARKET BY TYPE, THROUGH 2019
Table 69 : GLOBAL PROTEOMIC ARRAY MARKET BY TYPE, THROUGH 2019
Table 70 : GLOBAL PROTEOMIC BIOCHIP MARKET BY END-USER INDUSTRY, THROUGH 2019
Table 71 : GLOBAL PROTEOMIC ARRAY MARKET BY END-USER INDUSTRY, THROUGH 2019
Table 72 : GLOBAL PROTEOMIC LOAC MARKET BY END-USER INDUSTRY, THROUGH 2019
Table 73 : GLOBAL PROTEOMIC MARKET BY REGION, THROUGH 2019
Table 74 : GLOBAL PROTEOMIC DIAGNOSTIC MARKET BY REGION, THROUGH 2019
Table 75 : ARRAY-RELATED PROTEOMIC PATENTS BY REGION, 2004-2014
Table 76 : LAB-ON-A-CHIP-RELATED PROTEOMIC PATENTS BY REGION, 2004-2014
Table 77 : MASS SPECTROMETRY-RELATED PROTEOMIC PATENTS BY REGION, 2004-2014
Table 78 : APPLICATIONS FOR Y2H AND YCHEMH PROTEOMICS PLATFORMS
Table 79 : SOMALOGIC PROTEOMIC METHODS
Table 80 : PERSONALIZED PROTEOMICS COMPANIES
Table 81 : UNIVERSAL BIOSENSORS DIAGNOSTIC PIPELINE
List of Figures
Summary Figure : GLOBAL PROTEOMIC MARKET BY END-USER INDUSTRY, 2013-2019
Figure 1 : MASS SPECTROMETRY GENERALIZED WORKFLOW SCHEMATIC
Figure 2 : PROTEOMIC BIOCHIP AND ARRAY FORMATS
Figure 3 : CHROMATOGRAPHY PROTEOMICS WORKFLOW

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Proteomics Research Markets

Proteomics Research Markets

  • $ 4 200
  • Industry report
  • May 2015
  • by Kalorama Information

Proteomics Research Markets examines proteomics research processes in detail and in terms of their instrument and technological requirements relating to mass spectrometry, liquid chromatography and electrophoresis. ...

2015 Emerging Molecular Diagnostic Technologies, and Strategic Profiles of Leading Suppliers

2015 Emerging Molecular Diagnostic Technologies, and Strategic Profiles of Leading Suppliers

  • $ 3 500
  • Industry report
  • July 2015
  • by Venture Planning Group

This 185-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, ...

2015 Emerging Nucleic Acid Diagnostic Technologies, and Strategic Profiles of Leading Suppliers

2015 Emerging Nucleic Acid Diagnostic Technologies, and Strategic Profiles of Leading Suppliers

  • $ 3 500
  • Industry report
  • July 2015
  • by Venture Planning Group

This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, ...

Proteomics - World Panorama

May 2015 $ 3 750

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • August 2015
    107 pages
  • Blood Disease  

    Genome Sequenci...  

    Genetic  

  • United States  

View report >

Genome Sequencing Industry in the US

  • July 2015
    28 pages
  • Genome Sequenci...  

  • United States  

View report >

The future of the Healthcare Industry in Canada

  • June 2015
    29 pages
  • Genetic  

    Biomarker  

    Therapy  

  • Canada  

View report >

Rna Supply

5 months ago

Rice Industry In China

6 months ago

Rna Industry In The Us

6 months ago

Related Market Segments :

Proteomic

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.